Skip to content

Lead Motion Study

Lead Motion Study - Lead Motion Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41829
Enrollment
45
Registered
2015-03-18
Start date
2015-06-27
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

documentation of lead movement patients with ICD therapy

Interventions

None listed

Sponsors

BIOTRONIK SE & Co. KG
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: · Patient has provided written informed consent · Patient has a BIOTRONIK ICD or CRT-D · Patient has at least a BIOTRONIK Linoxsmart S-DX lead or any other BIOTRONIK lead model · Data about the implantation of the ICD/CRT-D, the lead(s) and the implanting physician are available at the investigation site · Patient is able to attend the X-ray procedure following a routine follow-up visit · None of the leads was implanted within the last three months · Patient had no cardiac intervention within the last two months · Patient has legal capacity and ability to consent

Exclusion criteria

Exclusion criteria: · Age

Design outcomes

Primary

MeasureTime frame
No primary or secondary endpoints were defined.

Secondary

MeasureTime frame
Data of interest in addition to the biplane cinefluoroscopy are: - Patient characteristics - ICD/CRT-D therapy characteristics, including data about implantation procedure - X-ray procedural data - Termination of individual patient study participation - Adverse and serious adverse events Exploratory data analyses will be used to describe the patient population.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)